XPA and neoplasm: Using the tumour suppressor gene XPA as an example, we directly show that a cancer-specific single-nucleotide mutation disrupting the PAS hexamer is sufficient to block pre-mRNA cleavage/polyadenylation and dampen the expression of mature mRNA (Figure 5C, E).